Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)

ClinicalTrials.gov ID: NCT00034957

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00034957. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:53 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary goal of the study is to evaluate an investigational drug's effectiveness as a treatment for Non small-cell lung cancer (NSCLC)

Study identification

NCT ID: NCT00034957
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Pfizer; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Investigational drug Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Oct 2002 (Actual)
Completion: Oct 2002 (Actual)
Last update posted: Feb 16, 2012

Ends 2002

United States locations

U.S. sites: 12
U.S. states: 8
U.S. cities: 12

Facility	City	State	ZIP	Site status
Research Center	Berkeley	California	94704	—
Research Center	Greenbrae	California	94904-2007	—
Research Center	Los Angeles	California	90048	—
Research Center	Rancho Mirage	California	92270	—
Research Center	Chicago	Illinois	60637-1463	—
Research Center	Louisville	Kentucky	40202	—
Research Center	West Boylston	Massachusetts	01583	—
Research Center	Ann Arbor	Michigan	48109	—
Research Center	Lebanon	New Hampshire	03756	—
Research Center	Nashville	Tennessee	37232-6868	—
Research Center	Arlington	Texas	76012	—
Research Center	Dallas	Texas	75390	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00034957, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 16, 2012 · Synced Nov 14, 2026